MATWIN is a French open-innovation platform supporting translational innovation in oncology in order to shorten the timeframe for transferring innovations to patients. Its main objective is to support innovative R&D projects either coming from academic laboratories or start-ups to promote early partnerships (industry, VC).
The program is based on a partnership with 15 major international laboratories and all the players concerned with developing innovation in the field (canceropoles, TTOs, clusters, incubators …).
WHY APPLY ?
You want to bring value to your innovation and benefit from international academic and industrial expertise, personalized coaching support with high added-value and access to a network of industrial decision-makers (international board). The MATWIN label will guarantee the quality and development potential of your project.
HOW TO APPLY ?
• Declare your intention to apply to the MATWIN platform
• Submit an application by October 31, 2019 (document on line on www.matwin.fr)
WHO CAN APPLY TO MATWIN ?
Any project leader from a public academic team or private structure (start-up type) having identified an innovation in oncology with a high transfer potential.
This innovation may concern the predictive, diagnostic, therapeutic or medical device areas.
Candidates will find in the MATWIN program ways to optimize the development potential of their project to match with oncology industrial expectations.
More informations -> https://matwin.fr/en/matwins-call-for-application/
+33 6 84 01 61 70